Views & Analysis | Perspectives on pharma industry issues

Digital

pharmaphorum podcast Episode 284, Mati Gill, AION Labs

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

Articles

Is collaboration key to the evolution of personalized medici...

Our latest interview is with Isabelle Tanneau, about the benefits, challenges and ethical issues facing pharma when it comes to personalized healthcare. As we enter a new era of healthcare, namely the personalized medicine era, it’s easy to question why pharma...

Articles

Interview with Kevin Hrusovsky part 3: the role of next gene...

Kevin Hrusovsky of PerkinElmer Inc. discusses the role of next generation sequencing in personalized medicine in the concluding part of his interview. Previously in this three-part interview Kevin shared with us the most recent exciting advances in the understanding of molecular interactions...

Articles

The evolution of personalised healthcare within oncology

Chris Teale discusses personalised medicine within the oncology field, looking at the way pharma now thinks about healthcare and some of the current barriers in companion diagnostics. The evolution of personalised healthcare has changed the diagnosis and prognosis of cancer patients. But in order to...

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.